Related Topics News -

     
 Detail   |   Print 
     
《大行》里昂:康諾亞周二急挫14% 料因市場情緒疲弱
2026-10-28T  
《大行》里昂:美國擬將生物科技納入COINS 料中國授權模式大致不受影響
2026-10-26T  
《大行》花旗:美國對外投資擬議規則料不影響創新藥授權及CDMO業務 相關股拋售屬過度反應
2026-10-26T  
《大行》匯豐研究:美國COINS法案擬限制對中國生物科技投資 惟BD交易未受影響
2026-10-26T  
《大行》大摩:中國生物科技股第四季催化劑前瞻 行業評級「吸引」
2026-10-23T  
國家藥監局召開「人工智能+藥品監管」工作推進會
2026-10-20T  
康諾亞:康悅達首三季度收入按年增2.27倍
2026-10-16T  
《大行》里昂:中國醫療保健授權交易動能增強 維持對行業正面看法
2026-10-06T  
《大行》野村:康方生物海外夥伴Summit獲阿斯利康20億美元投資 料股價反應正面
2026-09-30T  
《大行》匯豐研究對中國醫藥及生物科技股投資評級及目標價(表)
2026-09-29T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.